Publication
Major Histocompatibility Class-I (MHC-I) downregulation in glioblastoma is a poor prognostic factor but not a predictive indicator for treatment failure
Nadeem S. Butt, Maher Kurdi, Motaz M. Fadul, Sahar Hakamy, Bassam M.J. Addas, Eyad Faizo, Shadi Alkhayyat, Ahmed K. Bamaga, Taghreed Alsinani, Yousef Katib, Fahad Okal, Yazid Maghrabi, Abdulrahman J. Sabbagh, Rana Moshref, Sultan Albalawi, Alaa Alkhotani, Fawaz Mohammed, Nasser Mulla, Saleh Baeesa
Pathology - Research and Practice, October 2023, Elsevier
DOI: 10.1016/j.prp.2023.154816